Less than a year after purchasing private cell therapy company ImmPact Bio to help refresh its ailing CAR-T pipeline, manufacturing considerations have prompted Lyell Immunopharma to cut staff at its ...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the automobile manufacturing industry, including Ford (NYSE:F) and its peers. Much ...

As demand for precision medicine accelerates, CAR T and CAR Treg cell therapies are emerging as crucial tools in the fight against cancer and autoimmune diseases. For Thomas Fellner, PhD, head of ...

When you think of AI in the automotive industry, self-driving cars might be the first thing that comes to mine. However, AI is taking much more of a front seat in changing the automotive industry as a ...